Saisheng Pharmaceutical (06600.HK) announced that on May 8, 2024, the 35,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
赛生药业(06600.HK)：3.5万份购股权获行使
Saisheng Pharmaceutical (06600.HK): 35,000 share options exercised
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated